SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-282618
Filing Date
2023-11-24
Accepted
2023-11-24 09:30:55
Documents
10
Effectiveness Date
2023-11-24

Document Format Files

Seq Description Document Type Size
1 S-3ASR d554360ds3asr.htm S-3ASR 505835
2 EX-4.1 d554360dex41.htm EX-4.1 267582
3 EX-4.2 d554360dex42.htm EX-4.2 259469
4 EX-5.1 d554360dex51.htm EX-5.1 15555
5 EX-5.2 d554360dex52.htm EX-5.2 9099
6 EX-23.1 d554360dex231.htm EX-23.1 1668
7 EX-FILING FEES d554360dexfilingfees.htm EX-FILING FEES 84966
8 GRAPHIC g554360g04g04.jpg GRAPHIC 27477
9 GRAPHIC g554360g1122101453160.jpg GRAPHIC 2806
10 GRAPHIC g554360g33g33.jpg GRAPHIC 28350
  Complete submission text file 0001193125-23-282618.txt   1220303
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-275740 | Film No.: 231435268
SIC: 2835 In Vitro & In Vivo Diagnostic Substances